[ad_1]
Why is this important: White House officials had warned that the initial supply of the Johnson & Johnson vaccine would be limited due to production issues, although the company said it would honor its agreement to supply the United States with 100 million doses of the vaccine. ‘by the end of June.
“We are confident in our plans to deliver 100 million single-dose vaccines to the United States in the first half of 2021, and we continue to partner with the US government to explore all options to expedite delivery,” Nettles said.
The vaccine is 66% effective against the virus as a whole, but only showed 57% effectiveness in a trial in South Africa, where a problematic strain, B.1.315, has spread widely. This strain has been reported in 10 US states.
And after: The House panel will also hear from executives at Pfizer, Moderna, AstraZeneca and Novavax on how major vaccine makers are increasing production to meet the country’s vaccine demands.
Pfizer and Moderna have each pledged 300 million doses this year.
[ad_2]
Source link